Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chimeric Therapeutics Ltd. announced the issuance of 624,999,999 unquoted equity securities in the form of options set to expire on December 19, 2025, with an exercise price of $0.008. This latest move could attract investor interest as it involves a substantial number of options that were part of previously disclosed transactions. Investors in the stock market might find this development noteworthy as it could influence the company’s financial dynamics.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.